Sonova Holding AG SOON.SW
Composite 57/100; the shares have moved about 32% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.
Valuation ranks 34/100 — a moderate mark against it.
Quality ranks 70/100 — a moderate point in its favour. Momentum ranks 65/100 — a moderate point in its favour. Balance-sheet strength ranks 60/100 — a slight point in its favour.
Valuation ranks 34/100 — a moderate mark against it.
What the company does Sonova Holding AG designs, manufactures, and distributes hearing instruments, cochlear implants, and lifestyle-aligned hearables under brands such as Phonak, Unitron, Advanced Bionics, and Sennheiser. It sells directly to consumers via its own retail network and through independent audiologists and third-party chains.
Key financials Sonova reports strong profitability with ROE 20.5%, ROA 7.6%, and ROCE 75.1%. Gross margin is 73.7% and net margin 11.9%, supported by high interest coverage of 28.54 and a current ratio of 1.75. Revenue and EPS growth are negative at -1.0% and -8.4%, respectively.
Stock health The stock shows mixed momentum: +32.47% over 3 months, +6.87% over 6 months, but -2.83% over 12 months and -7.26% below its 52-week high. RSI(14) is elevated at 69.90, indicating potential near-term overbought conditions.
Price vs fair value The stock trades at a PREMIUM of 37.30% versus our fair-value estimate of 139.34 and is at a discount of 0.60% versus the analyst 12-month target of 223.72. - Trading at a 37.30% premium to fair value despite rich multiples (P/E 24.68, EV/EBITDA 15.30) (Valuation 38.6) - Negative revenue and EPS growth (-1.0%, -8.4%) amid strong profitability metrics (ROE 20.5%, ROCE 75.1%) - Elevated RSI(14) at 69.90 suggests potential near-term pullback risk - Analyst target implies limited upside (discount of 0.60%)
Looking forward Forward P/E of 20.88 and PEG of 1.14 suggest moderate valuation relative to growth, but weak recent growth (-1.0% revenue) and high valuation percentile (38.6) temper enthusiasm. Dividend yield is 2.1% with a payout ratio of 48.8%.
This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.
Data as of 2026-09-04, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.